Ettore D’Argento

1.7k total citations
52 papers, 890 citations indexed

About

Ettore D’Argento is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ettore D’Argento has authored 52 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Ettore D’Argento's work include Lung Cancer Treatments and Mutations (24 papers), Colorectal Cancer Treatments and Studies (17 papers) and Lung Cancer Research Studies (13 papers). Ettore D’Argento is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Colorectal Cancer Treatments and Studies (17 papers) and Lung Cancer Research Studies (13 papers). Ettore D’Argento collaborates with scholars based in Italy, United States and Japan. Ettore D’Argento's co-authors include Alessandra Cassano, Giovanni Schinzari, Carlo Barone, Sabrina Rossi, Michele Basso, Antonia Strippoli, Vincenzo Di Noia, Emilio Bria, Giampaolo Tortora and Emanuele Vita and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Medicine.

In The Last Decade

Ettore D’Argento

51 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ettore D’Argento Italy 18 538 382 218 160 114 52 890
Metin Özkan Türkiye 16 507 0.9× 366 1.0× 182 0.8× 168 1.1× 111 1.0× 100 925
Xiuyi Zhi China 17 327 0.6× 355 0.9× 355 1.6× 164 1.0× 47 0.4× 66 874
Steven Blotner United States 17 598 1.1× 223 0.6× 257 1.2× 177 1.1× 178 1.6× 36 1.1k
Kuan‐Yu Chen Taiwan 21 513 1.0× 579 1.5× 314 1.4× 163 1.0× 33 0.3× 39 1.1k
Sandra J. Casak United States 18 455 0.8× 215 0.6× 171 0.8× 107 0.7× 114 1.0× 32 1.0k
Monica Lencioni Italy 16 446 0.8× 214 0.6× 140 0.6× 117 0.7× 263 2.3× 51 791
Laurent Bastit France 10 647 1.2× 346 0.9× 128 0.6× 129 0.8× 102 0.9× 19 1.1k
Meredith K. Chuk United States 14 429 0.8× 260 0.7× 175 0.8× 116 0.7× 41 0.4× 29 858
Hitoshi Kameyama Japan 18 351 0.7× 224 0.6× 175 0.8× 138 0.9× 101 0.9× 116 984

Countries citing papers authored by Ettore D’Argento

Since Specialization
Citations

This map shows the geographic impact of Ettore D’Argento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ettore D’Argento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ettore D’Argento more than expected).

Fields of papers citing papers by Ettore D’Argento

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ettore D’Argento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ettore D’Argento. The network helps show where Ettore D’Argento may publish in the future.

Co-authorship network of co-authors of Ettore D’Argento

This figure shows the co-authorship network connecting the top 25 collaborators of Ettore D’Argento. A scholar is included among the top collaborators of Ettore D’Argento based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ettore D’Argento. Ettore D’Argento is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nachira, Dania, Maria Teresa Congedo, Ettore D’Argento, et al.. (2024). The Role of Human Papilloma Virus (HPV) in Primary Lung Cancer Development: State of the Art and Future Perspectives. Life. 14(1). 110–110. 4 indexed citations
2.
Sollena, Pietro, Alessandro Di Stefani, Ernesto Rossi, et al.. (2024). Quality of Life Impact in Patients with Cutaneous Toxicities Caused by Epidermal Growth Factor Receptor Inhibitors and Immunotherapy. Dermatology. 240(4). 523–530. 1 indexed citations
3.
Chiappetta, Marco, Maria Teresa Congedo, Elisa Meacci, et al.. (2022). Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics. Life. 12(11). 1753–1753. 2 indexed citations
4.
Piro, Geny, Emanuele Vita, Miriam Grazia Ferrara, et al.. (2022). Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer. Frontiers in Oncology. 12. 1026020–1026020. 13 indexed citations
5.
Ferrara, Miriam Grazia, Michele Simbolo, Sara Pilotto, et al.. (2021). Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities. Frontiers in Oncology. 11. 650293–650293. 32 indexed citations
6.
Noia, Vincenzo Di, Ettore D’Argento, Sabrina Rossi, et al.. (2021). Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies. ESMO Open. 6(6). 100280–100280. 36 indexed citations
7.
Minuti, Gabriele, Silvia Carpano, Ettore D’Argento, et al.. (2021). [Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]. PubMed. 112(10). 639–646. 1 indexed citations
8.
Ferrara, Miriam Grazia, Sara Pilotto, Carmine Carbone, et al.. (2021). The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures. Frontiers in Oncology. 11. 792385–792385. 3 indexed citations
9.
Ferrara, Miriam Grazia, Vincenzo Di Noia, Ettore D’Argento, et al.. (2020). Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives. Cancers. 12(5). 1196–1196. 63 indexed citations
10.
Carbone, Carmine, Geny Piro, Vincenzo Di Noia, et al.. (2019). Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer. Mediators of Inflammation. 2019. 1–10. 43 indexed citations
11.
12.
Noia, Vincenzo Di, Ettore D’Argento, Sara Pilotto, et al.. (2018). Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies. Expert Opinion on Biological Therapy. 18(9). 937–945. 12 indexed citations
13.
Inno, Alessandro, Vincenzo Di Noia, Maurizio Martini, et al.. (2018). Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis. Pathology & Oncology Research. 25(2). 513–520. 5 indexed citations
14.
Rossi, Sabrina, Michele Basso, Antonia Strippoli, et al.. (2017). Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?. Clinical Colorectal Cancer. 16(4). 264–274. 89 indexed citations
15.
Corallo, Salvatore, Ettore D’Argento, Antonia Strippoli, et al.. (2017). Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. Targeted Oncology. 12(2). 153–161. 18 indexed citations
16.
Rodriquenz, Maria Grazia, Sabrina Rossi, Riccardo Ricci, et al.. (2016). Gastrointestinal stromal tumors (GISTs) and second malignancies. Medicine. 95(38). e4718–e4718. 11 indexed citations
17.
Rossi, Sabrina, Michele Basso, Antonia Strippoli, et al.. (2015). Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease. Clinical Breast Cancer. 15(5). 307–312. 55 indexed citations
18.
Inno, Alessandro, Michele A. Basso, Fabio Maria Vecchio, et al.. (2011). Anastrozole-related acute hepatitis with autoimmune features: a case report. BMC Gastroenterology. 11(1). 32–32. 25 indexed citations
19.
Barone, Carlo, Michele A. Basso, Giovanni Schinzari, et al.. (2007). Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer. Gastric Cancer. 10(2). 104–111. 26 indexed citations
20.
Barone, Carlo, Matteo Landriscina, Michela Quirino, et al.. (2006). Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial. British Journal of Cancer. 96(1). 21–28. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Metin Özkan Breakdown of academic impact, for papers by Xiuyi Zhi Breakdown of academic impact, for papers by Steven Blotner Breakdown of academic impact, for papers by Kuan‐Yu Chen Breakdown of academic impact, for papers by Sandra J. Casak Breakdown of academic impact, for papers by Monica Lencioni Breakdown of academic impact, for papers by Laurent Bastit Breakdown of academic impact, for papers by Meredith K. Chuk Breakdown of academic impact, for papers by Hitoshi Kameyama
Rankless by CCL
2026